Cesca Therapeutics (KOOL) Tops Q4 EPS by 7c

Cesca Therapeutics (NASDAQ: KOOL) reported Q4 EPS of ($0.04), $0.07 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $4.28 million.

For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c